CDH
GNMX
Charles D. Hyman’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-15,143
| Closed | -$19K | – | 181 |
|
2018
Q3 | $19K | Hold |
15,143
| – | – | ﹤0.01% | 180 |
|
2018
Q2 | $17K | Hold |
15,143
| – | – | ﹤0.01% | 176 |
|
2018
Q1 | $30K | Hold |
15,143
| – | – | ﹤0.01% | 176 |
|
2017
Q4 | $18K | Hold |
15,143
| – | – | ﹤0.01% | 168 |
|
2017
Q3 | $19K | Hold |
15,143
| – | – | ﹤0.01% | 158 |
|
2017
Q2 | $20K | Hold |
15,143
| – | – | ﹤0.01% | 155 |
|
2017
Q1 | $28K | Hold |
15,143
| – | – | ﹤0.01% | 145 |
|
2016
Q4 | $78K | Hold |
15,143
| – | – | 0.01% | 139 |
|
2016
Q3 | $84K | Hold |
15,143
| – | – | 0.01% | 138 |
|
2016
Q2 | $84K | Hold |
15,143
| – | – | 0.01% | 139 |
|
2016
Q1 | $67K | Hold |
15,143
| – | – | 0.01% | 137 |
|
2015
Q4 | $91K | Buy |
15,143
+2,143
| +16% | +$12.9K | 0.02% | 138 |
|
2015
Q3 | $102K | Hold |
13,000
| – | – | 0.02% | 141 |
|
2015
Q2 | $80K | Hold |
13,000
| – | – | 0.01% | 145 |
|
2015
Q1 | $105K | Hold |
13,000
| – | – | 0.02% | 144 |
|
2014
Q4 | $66K | Sell |
13,000
-1,500
| -10% | -$7.62K | 0.01% | 144 |
|
2014
Q3 | $75K | Hold |
14,500
| – | – | 0.01% | 141 |
|
2014
Q2 | $113K | Hold |
14,500
| – | – | 0.02% | 143 |
|
2014
Q1 | $101K | Hold |
14,500
| – | – | 0.02% | 140 |
|
2013
Q4 | $87K | Hold |
14,500
| – | – | 0.02% | 138 |
|
2013
Q3 | $113K | Hold |
14,500
| – | – | 0.02% | 136 |
|
2013
Q2 | $55K | Buy |
+14,500
| New | +$55K | 0.01% | 136 |
|